Gut Microbiota Participates in Antithyroid Drug Induced Liver Injury Through the Lipopolysaccharide Related Signaling Pathway
Background: Drugs can alter the gut microbiota structure, and gut microbiota dysbiosis in turn is correlated with drug side effects through the intestinal endotoxemia hypothesis. Whether antithyroid drugs (including methimazole and propylthiouracil) cause gut microbiota dysbiosis and whether the gut...
Saved in:
Main Authors: | Jiayu Sun (Author), Fuya Zhao (Author), Baiqiang Lin (Author), Jing Feng (Author), Xin Wu (Author), Yang Liu (Author), Lei Zhao (Author), Biqiang Zhu (Author), Yunwei Wei (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
An Overview on the Proposed Mechanisms of Antithyroid Drugs-Induced Liver Injury
by: Reza Heidari, et al.
Published: (2015) -
Emodin Attenuates Lipopolysaccharide-Induced Acute Liver Injury via Inhibiting the TLR4 Signaling Pathway in vitro and in vivo
by: Yan Ding, et al.
Published: (2018) -
Metagenome of Gut Microbiota of Children With Nonalcoholic Fatty Liver Disease
by: Yuzhen Zhao, et al.
Published: (2019) -
Unusual antithyroid drug-induced hypoglycemia
by: Manish Gutch, et al.
Published: (2017) -
Clinical pharmacology of thyroid and antithyroid drugs
by: Stepanović-Petrović Radica, et al.
Published: (2022)